Market News
Stay updated with the latest market trends, earnings, and economic indicators.
UPI Transactions Moderate From Record High To Rs 28.9 Lakh Crore In June
UPI volumes have grown over 4.3 billion transactions and nearly Rs 5 lakh crore in value.
Nifty Outlook for July 2: Bulls aim for a range breakout even as IT remains a major drag
The Nifty Bank has a stronger setup in comparison to the Nifty and even though it remains in a range as well, it is reversing its underperformance from earlier in the week and is also moving back to the higher end of the range, having closed above the mark of 58,000 yet again. The 58,500 level remains the one to watch on the upside.
Ashiana Housing Q1 bookings decline as area sold falls
Ashiana Housing Q1 FY27 bookings fell in area and value, but it launched new OMA phases, bought 28.55 acres in Pune for a senior living project, and began handovers at Ashiana Nitara
Edelweiss AMC crosses ₹1 trn milestone in equity assets under management
The asset manager attributed the milestone to consistent fund performance, wider distribution and sustained retail participation through systematic investment plans across market cycles
Nifty reclaims 24,000 as auto, FMCG stocks drive market rebound
Benchmark indices snapped a two-day losing streak on Wednesday, supported by broad-based buying in auto, FMCG and financial stocks, while IT shares remained under pressure following KPIT Technologies' weak Q1 FY27 outlook. The Nifty reclaimed the 24,000 mark, while broader markets also ended higher. Positive global cues and value buying in beaten-down large-cap stocks lifted overall market sentiment.
Zaggle signs five-year agreement with HPCL for Drive Track Plus fleet programme
Zaggle has partnered with HPCL for its Drive Track Plus fleet card programme under a five-year agreement. The company said the contract value will depend on customer onboarding and fuel spending over the tenure.
Indian markets are not fragile; tepid Q1 earnings priced in: Radhika Gupta
Markets are either portrayed as unstoppable or extremely fragile, whereas the truth generally lies somewhere in between, says Radhika Gupta of Edelweiss Mutual Fund.
Kotak Institutional removes ABB India, Siemens, Cummins India from model portfolio
Kotak Institutional Equities' Sanjeev Prasad prefers private banks over IT and expensive industrial stocks, citing attractive valuations, stable credit growth and the potential for re-rating. He warned that AI-driven pricing pressure makes it difficult to value IT companies and said investors should avoid chasing richly valued capital goods and electrification stocks despite strong long-term themes. Healthcare, hospitality, retail and telecom remain among his preferred sectors.
Sensex today | Stock Market Live: Sensex rises 500 pts, Nifty crosses 24,000; KPIT hits 52-week low, tanks 15% - BusinessLine
Sensex today | Stock Market Live: Sensex rises 500 pts, Nifty crosses 24,000; KPIT hits 52-week low, tanks 15%BusinessLine
India's external financial position improves in FY2025-26
At the end of March 2026, net claims of non-residents on India declined by US$ 52.4 billion to US$ 209.9 billion during the January-March quarter. The improvement was driven by a US$ 40.1 billion decline in foreign-owned assets in India and a US$ 12.3 billion increase in Indian residents overseas financial assets. Exchange rate movements also affected the value of liabilities in US dollar terms.
How small-cap stocks become tomorrow's blue chips - Value Research
How small-cap stocks become tomorrow's blue chipsValue Research
Telangana plans drug discovery push to move Hyderabad up pharma value chain
Telangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by creating shared infrastructure and funding for startups and researchers. This ambitious plan aims to accelerate the development of next-generation therapies, including cell and gene therapies, by leveraging existing strengths and forging new partnerships, positioning Hyderabad for significant advancements in pharmaceutical innovation.